Search Results - Bondarenko, I.

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study by Bergh, J., Bondarenko, I., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N., Makhson, A., Cortes, J., Lortholary, A., Bischoff, J., Chan, Arlene, Delaloge, S., Huang, X., Kern, K., Giorgetti, C.

Get full text

Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breas... by Wolff, A., Lazar, A., Bondarenko, I., Garin, A., Brincat, S., Chow, L., Sun, Y., Neskovic-Konstantinovic, Z., Guimaraes, R., Fumoleau, P., Chan, Arlene, Hachemi, S., Strahs, A., Cincotta, M., Berkenblit, A., Krygowski, M., Kang, L.L., Moore, L., Hayes, D.

Get full text

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast... by Wolff, A., Lazar, A., Bondarenko, I., Garin, A., Brincat, S., Chow, L., Sun, Y., Neskovic-Konstanovic, Z., Guimaraes, R., Fumoleau, P., Chan, Arlene, Hachemi, S., Strahs, A., Cincotta, M., Berkenblit, A., Krygowski, M., Kang, L.L., Moore, L., Hayes, D.

Get full text